HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
EDSA - Edesa Biotech Inc - Stock Price Chart
TickerEDSA [NASD]
CompanyEdesa Biotech Inc
CountryCanada
IndustryBiotechnology
Market Cap53.01MEPS (TTM)-1.15
P/E-EPS this Y-28.74%
Forward P/E-EPS next Y-6.42%
PEG-EPS past 5Y-11.35%
P/S-EPS next 5Y-1.04%
P/B11.36EPS Q/Q41.70%
Dividend-Sales Q/Q-
Insider Own12.72%Inst Own45.43%
Insider Trans8.65%Inst Trans5.76%
Short Float19.36%EarningsFeb 13/a
Analyst Recom1.00Target Price14.00
Avg Volume4.10M52W Range0.72 - 8.74
Feb-24-26 09:15AM Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study (GlobeNewswire)
Feb-13-26 04:20PM Edesa Biotech Reports Fiscal 1st Quarter 2026 Results (GlobeNewswire)
Dec-12-25 04:20PM Edesa Biotech Reports Fiscal Year 2025 Results (GlobeNewswire)
Oct-31-25 04:30PM Edesa Biotech Announces Upcoming Conference Schedule (GlobeNewswire)
Oct-28-25 07:45AM Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study (GlobeNewswire)
Aug-08-25 04:35PM Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results (GlobeNewswire)
May-14-25 04:15PM Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results (GlobeNewswire)
Apr-28-25 04:30PM Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference (GlobeNewswire)
Apr-04-25 04:15PM Edesa Biotech Announces Chief Financial Officer Transition (GlobeNewswire)
Feb-14-25 04:15PM Edesa Biotech Reports Fiscal 1st Quarter 2025 Results (GlobeNewswire)
FLNA - Filana Therapeutics Inc - Stock Price Chart
TickerFLNA [NASD]
CompanyFilana Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap98.48MEPS (TTM)-2.20
P/E-EPS this Y-32.19%
Forward P/E-EPS next Y36.79%
PEG-EPS past 5Y-40.61%
P/S-EPS next 5Y-
P/B1.21EPS Q/Q61.59%
Dividend-Sales Q/Q-
Insider Own11.72%Inst Own28.56%
Insider Trans9.49%Inst Trans-0.08%
Short Float16.33%EarningsNov 12/b
Analyst Recom1.00Target Price8.00
Avg Volume857.58K52W Range1.15 - 4.98
Feb-19-26 08:00AM Cassava Announces Closure of U.S. Department of Justice Investigation (GlobeNewswire)
Jan-13-26 08:00AM Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer's Disease in the Journal of Prevention of Alzheimer's Disease (GlobeNewswire)
Dec-24-25 11:51AM HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Dec-23-25 08:00AM Cassava Announces Agreement to Settle Securities Class Action Litigation (GlobeNewswire)
Nov-25-25 07:39AM Cassava Pops After CEO Buys 150,000 Shares (GuruFocus.com)
Nov-12-25 08:00AM Cassava Reports Q3 2025 Financials Results and Provides Business Update (GlobeNewswire)
Oct-22-25 04:05PM Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
08:00AM Cassava Sciences Appoints Dawn C. Bir to the Board of Directors (GlobeNewswire)
Sep-24-25 04:58AM Cassava, Accenture to deploy sovereign AI solutions across Africa (Verdict)
Sep-23-25 12:13PM Cassava Boss Buys Big As Stock Collapses (GuruFocus.com)
AGH - Aureus Greenway Holdings Inc - Stock Price Chart
TickerAGH [NASD]
CompanyAureus Greenway Holdings Inc
CountryUSA
IndustryLeisure
Market Cap71.44MEPS (TTM)-0.19
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y47.62%
P/S24.38EPS next 5Y-
P/B2.05EPS Q/Q-1068.24%
Dividend-Sales Q/Q-22.89%
Insider Own51.67%Inst Own6.31%
Insider Trans0.00%Inst Trans-6.27%
Short Float2.09%Earnings-
Analyst Recom-Target Price-
Avg Volume572.26K52W Range0.52 - 8.25
Mar-10-26 12:29PM Donald Trump Jr. and Eric Trump back drone company Powerus (Quartz)
12:29PM Don Jr. and Eric Trump back drone company Powerus (Quartz)
01:03AM Eric Trump Touts Drone Investment After Report Suggests He And Don Jr. Are Backing Powerus, A Startup Vying To Fill The Void Left By China Ban (Benzinga)
Mar-09-26 05:02PM This Year's Defense-Stock Rally Has Largely Stalled Amid the Fighting in the Middle East (Investopedia)
04:20PM Watch This Trump-Backed Drone Company as Lockheed, RTX, Defense Stocks Pause (Barrons.com)
02:42PM Golf club firm owned by Trumps sons merges with drone manufacturer (The Guardian)
11:25AM Trump Familys Defense Investments Grow With New Drone Deal (Bloomberg)
10:05AM Aureus Greenway Shares Rise On Powerus Merger Agreement (Benzinga)
08:37AM Trump sons-backed Aureus to merge with drone maker Powerus (Reuters)
08:37AM Trump brothers-backed Aureus to merge with drone maker Powerus (Reuters)
PLYX - Polaryx Therapeutics Inc - Stock Price Chart
TickerPLYX [NASD]
CompanyPolaryx Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap262.29MEPS (TTM)-0.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B49.48EPS Q/Q-85.28%
Dividend-Sales Q/Q-
Insider Own91.81%Inst Own-
Insider Trans0.01%Inst Trans42.92%
Short Float5.60%Earnings-
Analyst Recom-Target Price-
Avg Volume3.39M52W Range2.20 - 48.91
Feb-27-26 08:30AM Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders (GlobeNewswire)
Feb-17-26 10:26AM Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans (Benzinga)
08:30AM Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial (GlobeNewswire)
Feb-10-26 08:30AM Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium (GlobeNewswire)
Feb-05-26 08:30AM Polaryx Therapeutics Welcomes New Members of the Board of Directors (GlobeNewswire)
Feb-04-26 08:40AM Polaryx to present late-breaker data related to Soteria ahead of trial (TipRanks)
Feb-03-26 08:30AM Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium as Company Prepares for SOTERIA Trial Launch (GlobeNewswire)
Feb-02-26 08:30AM Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol "PLYX" (GlobeNewswire)
CNSP - Cns Pharmaceuticals Inc - Stock Price Chart
TickerCNSP [NASD]
CompanyCns Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.09MEPS (TTM)-58.07
P/E-EPS this Y86.62%
Forward P/E-EPS next Y21.25%
PEG-EPS past 5Y70.59%
P/S-EPS next 5Y50.48%
P/B0.20EPS Q/Q96.20%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own20.03%
Insider Trans-Inst Trans0.84%
Short Float7.00%EarningsFeb 25
Analyst Recom1.00Target Price10.00
Avg Volume40.06K52W Range2.76 - 55.20
Today 08:35AM CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline (ACCESSWIRE)
Mar-02-26 08:25AM CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team (ACCESSWIRE)
Feb-17-26 08:25AM CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation (ACCESSWIRE)
Jan-27-26 09:00AM CNS Pharmaceuticals Issues Letter to Shareholders (ACCESSWIRE)
Dec-17-25 07:00AM CNS Pharmaceuticals Announces CEO Transition (ACCESSWIRE)
Nov-17-25 08:35AM CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update (ACCESSWIRE)
Nov-10-25 08:45AM CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting (ACCESSWIRE)
Sep-13-25 09:05AM CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap (TipRanks)
Sep-03-25 09:15AM CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference (ACCESSWIRE)
Aug-15-25 08:05AM CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update (ACCESSWIRE)
PIII - P3 Health Partners Inc - Stock Price Chart
TickerPIII [NASD]
CompanyP3 Health Partners Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap26.56MEPS (TTM)-43.00
P/E-EPS this Y36.21%
Forward P/E-EPS next Y41.00%
PEG-EPS past 5Y-8.00%
P/S0.02EPS next 5Y-
P/B-EPS Q/Q38.43%
Dividend-Sales Q/Q-4.66%
Insider Own45.14%Inst Own8.31%
Insider Trans0.00%Inst Trans-0.80%
Short Float4.40%EarningsNov 13/a
Analyst Recom1.67Target Price10.83
Avg Volume66.65K52W Range1.52 - 11.30
Dec-02-25 04:05PM P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO (Business Wire)
Nov-24-25 08:01PM P3 Health Partners Inc (PIII) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
04:05PM P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference (Newsfile)
Nov-13-25 05:30PM P3 Health Partners Announces Third Quarter 2025 Results (Business Wire)
Oct-21-25 04:05PM P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call (Business Wire)
Sep-17-25 04:05PM P3 Health Partners to Participate in the Jefferies Healthcare Services Conference (Business Wire)
Aug-25-25 09:30AM Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States (PR Newswire)
Aug-15-25 03:04PM P3 Health Partners Inc (PIII) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Aug-14-25 05:15PM P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM P3 Health Partners Announces Second Quarter 2025 Results (Business Wire)
VTVT - vTv Therapeutics Inc - Stock Price Chart
TickerVTVT [NASD]
CompanyvTv Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap147.14MEPS (TTM)-3.35
P/E-EPS this Y-23.59%
Forward P/E-EPS next Y-24.84%
PEG-EPS past 5Y14.99%
P/S-EPS next 5Y-15.18%
P/B2.15EPS Q/Q-4.20%
Dividend-Sales Q/Q-100.00%
Insider Own35.13%Inst Own24.52%
Insider Trans0.00%Inst Trans1.82%
Short Float2.24%EarningsMar 10/a
Analyst Recom1.00Target Price55.25
Avg Volume28.29K52W Range14.00 - 44.00
Mar-10-26 04:17PM VTv Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-03-26 10:20AM vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737 (Insider Monkey)
Feb-13-26 08:00AM vTv Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-02-26 08:00AM vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 (GlobeNewswire)
Jan-05-26 11:40AM An Alzheimers Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? (Barchart)
Dec-24-25 12:00PM vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-18-25 04:05PM vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health (GlobeNewswire)
Nov-24-25 09:55AM Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect? (Zacks)
Nov-11-25 12:00PM All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy (Zacks)
AHG - Akso Health Group ADR - Stock Price Chart
TickerAHG [NASD]
CompanyAkso Health Group ADR
CountryChina
IndustryMedical Distribution
Market Cap1.67BEPS (TTM)-0.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y35.90%
P/S112.64EPS next 5Y-
P/B8.43EPS Q/Q40.33%
Dividend-Sales Q/Q25.47%
Insider Own-Inst Own0.02%
Insider Trans-Inst Trans10.87%
Short Float0.08%Earnings-
Analyst Recom-Target Price4.00
Avg Volume17.98K52W Range0.83 - 2.10
Feb-03-26 09:00AM Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative (PR Newswire)
Feb-18-25 08:30AM AHG Utilizes DeepSeek to Advance AI in Healthcare (PR Newswire)
Jul-02-24 07:40AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-30-24 06:45AM 7 A-Rated Penny Stocks Work Betting On in H2 2024 (InvestorPlace)
Jan-31-24 04:00PM AHG Announces Plan to Acquire Online Clinic (GlobeNewswire)
Oct-16-23 10:30AM Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement (GlobeNewswire)
Apr-27-23 10:30AM Akso Health Group Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
Mar-06-23 04:05PM Akso Health Group Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency (GlobeNewswire)
Oct-28-22 04:10PM Akso Health Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (PR Newswire)
Aug-17-22 06:00AM Akso Health Group Receives Notice of Filing Delinquency From Nasdaq (PR Newswire)
RCKT - Rocket Pharmaceuticals Inc - Stock Price Chart
TickerRCKT [NASD, RUT]
CompanyRocket Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap541.22MEPS (TTM)-2.01
P/E-EPS this Y25.30%
Forward P/E-EPS next Y20.74%
PEG-EPS past 5Y4.46%
P/S-EPS next 5Y23.69%
P/B1.95EPS Q/Q38.49%
Dividend-Sales Q/Q-
Insider Own6.99%Inst Own83.18%
Insider Trans-0.88%Inst Trans-4.84%
Short Float13.85%EarningsFeb 26/a
Analyst Recom2.54Target Price8.22
Avg Volume2.49M52W Range2.19 - 8.90
Mar-03-26 01:15PM Wedbush sees Rocket Pharmaceuticals as significantly undervalued as cardiac gene therapy pipeline advances (Proactive)
Feb-27-26 12:46PM RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus (Zacks)
Feb-26-26 04:04PM Rocket Pharmaceuticals: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress (Business Wire)
Feb-23-26 07:00AM Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences (Business Wire)
Feb-18-26 07:44PM Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery (Insider Monkey)
Jan-05-26 07:00AM Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-15-25 11:10PM Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position (Insider Monkey)
Dec-09-25 11:57AM Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions (PR Newswire)
Nov-25-25 07:00AM Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference (Business Wire)
OCC - Optical Cable Corp - Stock Price Chart
TickerOCC [NASD]
CompanyOptical Cable Corp
CountryUSA
IndustryCommunication Equipment
Market Cap70.51MEPS (TTM)-0.09
P/E-EPS this Y92.86%
Forward P/E22.08EPS next Y33.33%
PEG-EPS past 5Y26.31%
P/S0.96EPS next 5Y-
P/B3.59EPS Q/Q67.33%
Dividend-Sales Q/Q4.37%
Insider Own35.41%Inst Own18.08%
Insider Trans0.00%Inst Trans-1.63%
Short Float0.85%EarningsMar 10/b
Analyst Recom1.00Target Price9.00
Avg Volume128.56K52W Range2.40 - 11.50
Mar-10-26 05:02PM Optical Cable Corp (OCC) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Optimism for ... (GuruFocus.com)
08:00AM OPTICAL CABLE CORPORATION REPORTS FIRST QUARTER OF FISCAL YEAR 2026 FINANCIAL RESULTS (PR Newswire)
Mar-05-26 04:15PM OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS FIRST QUARTER OF FISCAL YEAR 2026 RESULTS (PR Newswire)
Dec-18-25 06:00PM Optical Cable Corp (OCC) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Net Loss ... (GuruFocus.com)
08:00AM OPTICAL CABLE CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS (PR Newswire)
Dec-16-25 05:45PM OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FISCAL YEAR 2025 RESULTS (PR Newswire)
Nov-14-25 04:10PM Blue Ridge, which erred with fintechs, exits consent order (American Banker)
Sep-12-25 03:03AM Optical Cable Corp (OCC) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com)
Sep-11-25 08:00AM OPTICAL CABLE CORPORATION REPORTS THIRD QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS (PR Newswire)
Sep-10-25 12:45PM OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS THIRD QUARTER OF FISCAL YEAR 2025 RESULTS (PR Newswire)
12345678910⋯20
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)